Publisher Correction: Valproic acid targets IDH1 mutants through alteration of lipid metabolism

Affiliations

• ¹ Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
• ² Department of Neurology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA.
• ³ Department of Neurosurgery, Department of Cell and Developmental Biology, and Rogel Cancer Center, University of Michigan Medical School, Ann Arbor, MI, USA.
• ⁴ Kettering Health Network, Kettering, OH, USA.
• ⁵ Department of Psychiatry and Behavioral Sciences and the UCLA Intellectual and Developmental Disabilities Research Center, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. hkornblum@mednet.ucla.edu.
• ⁶ Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, UCLA, Los Angeles, CA, USA. hkornblum@mednet.ucla.edu.